Symbol="BLUE"
AssetType="Common Stock"
Name="Bluebird bio Inc"
Description="bluebird bio, Inc., a biotechnology company, researches, develops and markets transformative gene therapies for serious genetic diseases and cancer. The company is headquartered in Cambridge, Massachusetts."
CIK="1293971"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="60 BINNEY STREET, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="400004000"
EBITDA="-133210000"
PERatio="None"
PEGRatio="0.32"
BookValue="2.715"
DividendPerShare="0"
DividendYield="0"
EPS="-0.83"
RevenuePerShareTTM="0.099"
ProfitMargin="0"
OperatingMarginTTM="-14.66"
ReturnOnAssetsTTM="-0.139"
ReturnOnEquityTTM="-0.409"
RevenueTTM="9404000"
GrossProfitTTM="-247244000"
DilutedEPSTTM="-0.83"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="3.536"
AnalystTargetPrice="7.36"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="125.49"
PriceToBookRatio="4.368"
EVToRevenue="161.97"
EVToEBITDA="-1.909"
Beta="0.947"
num_52WeekHigh="8.58"
num_52WeekLow="2.78"
num_50DayMovingAverage="3.551"
num_200DayMovingAverage="4.935"
SharesOutstanding="106953000"
DividendDate="None"
ExDividendDate="None"
symbol="BLUE"
open="3.74"
high="3.83"
low="3.72"
price="3.77"
volume="2021377.00"
latest_trading_day="2023-08-31"
previous_close="3.74"
change="0.03"
change_percent="0.8021%"
aroon_positive_momentum_days="42"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="42"
Volume_recent_avg="4312851"
Change_recent_avg="-0.01"
Delta_recent_avg="0.3"
Variance_recent_avg="0.15"
Change_ratio_recent_avg="-0.45"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="42"
Aroon_momentum_negative="58"
image_negative_thumbnail_id_1="1094"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0127.jpeg"
image_negative_thumbnail_id_2="503"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0102.jpeg"
image_neutral_thumbnail_id_1="544"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0055.jpeg"
image_neutral_thumbnail_id_2="569"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0030.jpeg"
image_positive_thumbnail_id_1="948"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0110.jpeg"
image_positive_thumbnail_id_2="1010"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0172.jpeg"
image_professor_thumbnail_id_1="1184"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0018.jpeg"
image_professor_thumbnail_id_2="1189"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0023.jpeg"
